Try our beta test site

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01237236
First received: November 5, 2010
Last updated: February 9, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 15, 2017
  Estimated Primary Completion Date: March 15, 2017 (Final data collection date for primary outcome measure)